Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MDVN $105.33 8.3600 +8.62%
PBYI $90.60 6.4700 +7.69%
BDSI $8.15 0.5000 +6.54%
OGXI $3.45 0.2100 +6.48%
TKMR $10.83 0.5800 +5.66%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CTIX $2.57 -0.1400 -5.17%
SNSS $1.40 -0.0750 -5.10%
MNKD $4.29 -0.1700 -3.81%
TLOG $2.35 -0.0900 -3.69%
CCXI $8.24 -0.3000 -3.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Magnetic Nanoparticles Could Be Key To Effective Immunotherapy

(Johns Hopkins) July 15, 2015 - Results of a study led by Johns Hopkins investigators suggests that a device composed of a magnetic column paired with custom-made magnetic nanoparticles may hold a key to bringing immunotherapy into widespread and successful clinical use.
read press release 



Genetic Expression 'Predicts Lung Cancer Survival’

(University of Oxford [UK]) July 13, 2015 - A study led by Oxford University researchers and colleagues at the National Cancer Institute, Milan, Italy has shed light on a key puzzle thrown up in some lung cancer screening programmes.
read article 



Radiation From Mammograms May Be Lower Than Thought

(HealthDay News) July 15, 2015 - Variations in tissue type throughout the breast account for difference, study says.
read article 



Dietary Intervention Primes Triple-Negative Breast Cancer for Targeted Therapy

(University of Wisconsin-Madison) July 14, 2015 - A diet that starves triple-negative breast cancer cells of an essential nutrient primes the cancer cells to be more easily killed by a targeted antibody treatment, UW Carbone Cancer Center scientists report in a recent publication.
read article 



Anti-Stress Hormone May Provide Indication Of Breast Cancer Risk

(Lund University [Lund, Sweden]) July 14, 2015 - A new study from Lund University in Sweden shows that women with low levels of an anti-stress hormone have an increased risk of getting breast cancer. The study is the first of its kind on humans and confirms previous similar observations from animal experiments.
read article 



Why Breast-Cancer Survivors Gain More Weight

(TIME) July 15, 2015 - Tumors and treatment may make it easier to put on pounds, and the latest research shows why breast cancer patients should be aware of the dangers of gaining too much.
read article 



Test May Identify Poor Prognosis for Some Patients with Lung Cancer

(NCI/Cancer Currents blog) July 13, 2015 - A panel of three genetic markers may help to identify patients with early-stage lung cancer who have a very strong likelihood of their disease returning after surgery, according to findings from a study by NCI researchers.
read article 



On Research Review Boards, Conflict-Of-Interest Reporting Improves

(Reuters Health) July 14, 2015 - Many doctors who serve on hospital panels overseeing the ethics and safety of human research trials have industry relationships that may compromise their objectivity, but reporting these conflicts has become more common over the past 10 years, according to a new study.
read article 



Broader Statin Use Gets Support From 2 New Studies

(New York Times) July 14, 2015 - The studies lend support to controversial new guidelines that could vastly increase the number of Americans advised to take cholesterol-lowering drugs.
read article 



Study: Silent Cancer in Moms a Rare Result in Prenatal Tests

(New York Times/Associated Press) July 13, 2015 - For pregnant women, abnormal results from certain prenatal tests may signal that something is wrong — with the moms-to-be, not the fetus, a preliminary study suggests.
read article 



'Surgeon Scorecard' Measures Docs By Complications

(USA Today) July 14, 2015 - Surgeons around the country are now scored against their peers in a new statistic developed by a non-profit news organization that goes beyond hospital-level data, providing a never-before-available tool for consumers and generating debate and some angst in the surgical community.
read article 



Health Insurer Mergers Will Pressure Pharma Over High-Cost Drugs

(Wall Street Journal) July 13, 2015 - As the nation’s biggest health insurers jockey for supremacy, drug makers should brace for added pressure because doctors are likely to face stingier reimbursement over the next few years. And cancer treatments, in particular, are expected to be targeted, according to a report from Moody’s Investor Service.
read article (paid subscription required) 



Takeda Submits New Drug Application for Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma

(Digital Journal) July 14, 2015 - Takeda Pharmaceutical Company Limited today announced that a New Drug Application (NDA) has been submitted to the United States (U.S.) Food and Drug Administration (FDA) for ixazomib, an investigational oral proteasome inhibitor for the treatment of patients with relapsed and/or refractory multiple myeloma.
read article 



In Race to Treat Muscle-Wasting Disease, Sarepta Seeks Purchases

(Bloomberg) July 14, 2015 - Sarepta Therapeutics Inc. is looking to buy another drug in an escalating battle with bigger rival BioMarin Pharmaceutical Inc. to treat Duchenne muscular dystrophy, the rare and deadly muscle-wasting disease.
read article 



Stanford Health Care Opens its New Stanford Cancer Center South Bay

(Stanford Health Care) July 13, 2015 - Stanford Health Care today officially opened its new Stanford Cancer Center South Bay in San Jose. Located at 2589 Samaritan Drive in San Jose, the Stanford Cancer Center South Bay brings Stanford Health Care's renowned comprehensive cancer services to the South Bay in a state-of-the-art, patient-oriented center.
read press release 



Susan G. Komen® Grants $2.3 Million to Help Breast Cancer Patients and Families

(Susan G. Komen) July 14, 2015 — 2015 funding builds on Komen-funded programs for medical supplies, living expenses, access to patient programs for low-income and uninsured.
read press release 



Changes Ahead for the Chemotherapy Foundation Symposium

(Oncology Times) July 13, 2015 - For meeting-goers, the short, targeted presentations about novel cancer therapeutics and developments in care at the 2015 Chemotherapy Foundation Symposium will still feel very much like meetings past—but behind the scenes, the meeting will look rather different.
read article 



Will Specialty Oncology Products Follow the Sovaldi Way?

(AJMC) July 13, 2015 - The approval of Sovaldi in 2014 to treat hepatitis C revolutionized the disease treatment landscape. Following the subsequent cost debates, and widespread criticism of the 12-week, $84,000 Sovaldi regimen, Medicaid and some other health plans took a more restrictive approach, limiting access to the drug to patients with more advanced disease.
read article 



What Is Value to the Cancer Patient, Oncologist, and Payer?

(Medscape Medical News) July 13, 2015 - Price and value are not the same, and it was that premise that drove ASCO to focus on value rather than on cost alone.
read article (free registration required) 



Biocept Launches Diagnostic Assay for BRAF Mutations in Patients with Melanoma

(Yahoo! Finance) July 14, 2015 - New test provides physicians with a liquid biopsy option to reach informed treatment decisions for patients with melanoma and other tumors.
read article 



July 2015 Decisions News Release

(Scottish Medicines Consortium) July 13, 2015 - The Committee was unable to recommend two other medicines considered under the PACE process, olaparib (Lynparza) for ovarian cancer and vinflunine (Javlor) for cancer of the bladder and the urinary tract.
read press release 



QIAGEN Companion Diagnostic Wins FDA Approval For Use With IRESSA

(QIAGEN) July 13, 2015 - therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.
read corporate press release 



Cleave Biosciences Gets FDA Orphan Status For CB-5083 To Treat Multiple Myeloma

(Pharmaceutical Business Review) July 14, 2015 - US-based biopharmaceutical firm Cleave Biosciences has received orphan drug designation from the US Food and Drug Administration (FDA) for its lead drug candidate, CB-5083, to treat multiple myeloma.
read article 



Cancer Spread 'Lynchpin’ Identified

(Yahoo! News [UK & Ireland]/Press Association) July 13, 2015 - A molecule described as the "lynchpin" of cancer spread has been identified, paving the way to potentially life-saving treatments.
read article 



Celator® Pharmaceuticals Announces Start of Clinical Study of CPX-351 in Acute Myeloid Leukemia Patients at High Risk for Induction Mortality

(TheStreet) July 14, 2015 - Celator Pharmaceuticals, Inc. today announced that patients have been enrolled in an investigator-initiated Phase 2 clinical study evaluating CPX-351 (cyatarabine:daunorubicin) Liposome Injection as a treatment for patients with newly diagnosed Acute Myeloid Leukemia (AML) at high risk for induction treatment mortality.
read article